26
Participants
Start Date
May 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
ALT-801
Dose escalation (0.015 mg/kg, 0.04 mg/kg, 0.08 mg/kg, 0.12 mg/kg, 0.14 mg/kg, 0.16 mg/kg), intravenous infusions, two treatment cycle, each cycle with 4 daily on-dose infusion, 10 days rest between cycles.
MD Anderson Cancer Center Orlando, Orlando
H. Lee Moffitt Cancer Center & Research Institute, Tampa
University of Colorado, Anschutz Cancer Pavillion, Aurora
University of Washington, Seattle Cancer Care Center, Seattle
Lead Sponsor
Altor BioScience
INDUSTRY